Epitopea

About:

Epitopea is a transatlantic cancer immunotherapeutics company.

Website: https://www.epitopea.com

Top Investors: Cambridge Innovation Capital, Fonds de solidarité FTQ, Innovate UK, adMare Bio Innovations, Investissement Quebec

Description:

Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, and bioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.